Jon‐Paul Khoo

44.2k total citations · 1 hit paper
7 papers, 472 citations indexed

About

Jon‐Paul Khoo is a scholar working on Experimental and Cognitive Psychology, Pharmacology and Biological Psychiatry. According to data from OpenAlex, Jon‐Paul Khoo has authored 7 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Experimental and Cognitive Psychology, 2 papers in Pharmacology and 2 papers in Biological Psychiatry. Recurrent topics in Jon‐Paul Khoo's work include Natural Compound Pharmacology Studies (2 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers) and Treatment of Major Depression (2 papers). Jon‐Paul Khoo is often cited by papers focused on Natural Compound Pharmacology Studies (2 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers) and Treatment of Major Depression (2 papers). Jon‐Paul Khoo collaborates with scholars based in Australia, South Africa and Canada. Jon‐Paul Khoo's co-authors include Theo Vos, Alize J Ferrari, Emily Stockings, Louisa Degenhardt, Harvey Whiteford, Holly E Erskine, Dan J. Stein, Valérie Olivier, Michael Van Ameringen and F. Picarel-Blanchot and has published in prestigious journals such as Australian & New Zealand Journal of Psychiatry, Bipolar Disorders and Frontiers in Psychiatry.

In The Last Decade

Jon‐Paul Khoo

7 papers receiving 463 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013

2016 368 citations Alize J Ferrari, Emily Stockings et al. Bipolar Disorders profile →

Peers

Countries citing papers authored by Jon‐Paul Khoo

Since Specialization

Citations

This map shows the geographic impact of Jon‐Paul Khoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon‐Paul Khoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon‐Paul Khoo more than expected).

Fields of papers citing papers by Jon‐Paul Khoo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon‐Paul Khoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon‐Paul Khoo. The network helps show where Jon‐Paul Khoo may publish in the future.

Co-authorship network of co-authors of Jon‐Paul Khoo

This figure shows the co-authorship network connecting the top 25 collaborators of Jon‐Paul Khoo. A scholar is included among the top collaborators of Jon‐Paul Khoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon‐Paul Khoo. Jon‐Paul Khoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Efficacy of Agomelatine 25–50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies 2021 ·Advances in Therapy ·Dan J. Stein, Jon‐Paul Khoo, F. Picarel-Blanchot, Valérie Olivier, Michael Van Ameringen	17
2	The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia 2019 ·Frontiers in Psychiatry ·Melanie M. Ashton, Olivia Dean, Adam J. Walker, Chiara C. Bortolasci, Chee H. Ng, Malcolm Hopwood, Brian H. Harvey, Marisa Möller, John J. McGrath, Wolfgang Marx, Alyna Turner, Seetal Dodd, James G. Scott, Jon‐Paul Khoo, Ken Walder, Jerome Sarris, Michael Berk	20
3	12-week double-blind randomized multicenter study of efficacy and safety of agomelatine (25–50 mg/day) versus escitalopram (10–20 mg/day) in out-patients with severe generalized anxiety disorder 2018 ·European Neuropsychopharmacology ·Dan J. Stein, Jon‐Paul Khoo, Antti Ahokas, Marek Jarema, Michael Van Ameringen, L. Vavrušová, Cyril Höschl, Michael Bauer, István Bitter, Sergey Mosolov, Valérie Olivier, (unknown), F. Picarel-Blanchot, Christian de Bodinat	23
4	Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial 2018 ·Brazilian Journal of Psychiatry ·Melanie M. Ashton, Michael Berk, Chee H. Ng, Malcolm Hopwood, Seetal Dodd, Alyna Turner, Ellie Brown, Felice N. Jacka, Sue Cotton, Jon‐Paul Khoo, Mary Lou Chatterton, Bianca E. Kavanagh, (unknown), (unknown), Brian H. Harvey, Jerome Sarris, Gin S. Malhi, Nathan Dowling, Olivia Dean	9
5	The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013 breakdown → 2016 ·Bipolar Disorders ·Alize J Ferrari, Emily Stockings, Jon‐Paul Khoo, Holly E Erskine, Louisa Degenhardt, Theo Vos, Harvey Whiteford	368
6	Mood stabilisers 2012 ·Australian Prescriber ·Jon‐Paul Khoo	1
7	A Consensus Statement for Safety Monitoring Guidelines of Treatments for Major Depressive Disorder 2011 ·Australian & New Zealand Journal of Psychiatry ·Seetal Dodd, Gin S. Malhi, John Tiller, Isaac Schweitzer, Ian B. Hickie, Jon‐Paul Khoo, Darryl Bassett, Bill Lyndon, Philip B. Mitchell, Gordon Parker, Paul B. Fitzgerald, Marc Udina, Ajeet Singh, Steven Moylan, Francesco Giorlando, Carolyn Doughty, Christopher G. Davey, (unknown), Michael Berk	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact